Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Women with Microvascular Angina (GAP)
NCT02602600Phase 4Completed
- Start
- Nov 2015
- Primary completion
- Apr 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in microvascular angina (MVA). Started Nov 2015; status: completed.
02
Drugs
03
Conditions
microvascular angina (MVA)
Beyond the preview
Go deeper on NCT02602600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02602600.